HomeSANN • SWX
add
Santhera Pharmaceuticals Holding AG
Previous close
CHF 8.35
Day range
CHF 8.02 - CHF 8.44
Year range
CHF 7.21 - CHF 11.44
Market cap
105.56M CHF
Avg Volume
13.34K
P/E ratio
1.42
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 7.06M | 258.31% |
Operating expense | 13.32M | 19.38% |
Net income | -7.63M | 34.59% |
Net profit margin | -108.14 | 81.75% |
Earnings per share | -1.35 | — |
EBITDA | -7.48M | 19.00% |
Effective tax rate | -1.15% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.49M | 885.13% |
Total assets | 108.25M | 71.61% |
Total liabilities | 60.19M | -43.13% |
Total equity | 48.06M | — |
Shares outstanding | 11.70M | — |
Price to book | 2.03 | — |
Return on assets | -20.49% | — |
Return on capital | -29.79% | — |
Cash Flow
Net change in cash
(CHF) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.63M | 34.59% |
Cash from operations | -7.64M | 0.49% |
Cash from investing | 5.00K | -99.82% |
Cash from financing | -179.00K | -103.59% |
Net change in cash | -6.94M | -4,423.68% |
Free cash flow | -4.16M | 40.50% |
About
Founded
2004
Website
Employees
45